Aris is an established Clinical Trial Management company dedicated to delivering the highest level of performance and
expertise across all stages of the clinical trial process.
Time Frame |
Project Scope |
Indication |
Therapy |
Services Provided |
2005-2006 |
Phase I
20 Subjects
1 Site |
Attention Deficit
Hyperactivity Disorder |
Amphetamine |
Clinical Trial Monitoring
Site Management
Document Management |
2005 |
Phase I
20 Subjects
1 Site |
Attention Deficit
Hyperactivity Disorder |
Amphetamine |
Clinical Trial Monitoring
Site Management
Document Management |
2005-2006 |
Phase III
40 Subjects
10 Sites |
Renal Cell Carcinoma |
Heat Shock Protein |
Clinical Trial Monitoring |
2005 |
Phase I
18 Subjects
1Site |
Attention Deficit
Hyperactivity Disorder |
Amphetamine |
Clinical Trial Monitoring
Site Management
Document Management |
2005-2006 |
Phase IV
300 Subjects
14 Sites |
Cardiology |
Diagnostic Device |
Clinical Trial Monitoring
Project Management
Site Management
Document Management |
2003-2005 |
Phase III Study
750 Subjects
80 Sites |
Mucositis |
Cytokine Inhibitor |
Clinical Trial Monitoring
Project Management
Site Management
Site Selection
Document Management |
2003-2004 |
Phase I Study
18 subjects
1 site |
Attention Deficit
Hyperactivity Disorder |
Amphetamine |
Clinical Trial Monitoring
Project Management
Site Management
Document Management
Medical Monitoring |
2003 |
Retrospective Study
1000 subjects
10 sites |
Anemia |
Cellular Growth Factor |
Project Management
Site Management
Document Management |
2003 |
Phase I Study
48 subjects
1 site |
GI Inflammation |
Anti-inflammatory |
Clinical Trial Monitoring |
2003 |
Retrospective Study
3000 subjects
60 sites |
Anemia |
Cellular Growth Factor |
Project Management
Site Management
Document Management |
2001-2003 |
Phase III Study
300 subjects
30 sites |
Chronic Pain |
Opiate |
Clinical Trial Monitoring
Project Management
Site Management
Site Selection
Document Management
Medical Monitoring |
2002 |
Phase II Study
6 subjects
1 site |
Dependency |
Opiate |
Clinical Trial Monitoring |
2000-2002 |
2 Phase III Studies
800 subjects
56 sites |
Osteoarthritis |
Opiate |
Clinical Trial Monitoring
Project Management
Site Management
Document Management
Medical Monitoring |
2000 |
Phase III Study
450 subjects
40 sites |
Attention Deficit
Hyperactivity Disorder |
Amphetamine |
Project Rescue |
1999-2001 |
2 Phase III Studies
96 subjects
30 sites |
HIV Disease |
Non-Nucleoside Reverse
Transcriptase Inhibitor |
Clinical Trial Monitoring
Project Management
Document Management |
1999-2000 |
Phase II Study
20 subjects
1 site |
Ophthalmology:
posterior chamber
inflammation secondary
to retinal disorders |
Steroid |
Clinical Trial Monitoring
Project Management |
1997-1999 |
Phase III Study
300 subjects
18 sites |
Ophthalmology:
inflammation secondary to
cataract surgery |
Steroid |
Clinical Trial Monitoring
Project Management |